These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37525188)

  • 1. Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2.
    Chiang HL; Liang KH; Lu RM; Kuo TW; Lin YL; Wu HC
    J Biomed Sci; 2023 Jul; 30(1):59. PubMed ID: 37525188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity.
    Muik A; Lui BG; Quandt J; Diao H; Fu Y; Bacher M; Gordon J; Toker A; Grosser J; Ozhelvaci O; Grikscheit K; Hoehl S; Kohmer N; Lustig Y; Regev-Yochay G; Ciesek S; Beguir K; Poran A; Vogler I; Türeci Ö; Sahin U
    Cell Rep; 2023 Aug; 42(8):112888. PubMed ID: 37527039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of a booster vaccine against COVID-19 based on antigenic distance.
    Hu YF; Yuen TT; Gong HR; Hu B; Hu JC; Lin XS; Rong L; Zhou CL; Chen LL; Wang X; Lei C; Yau T; Hung IF; To KK; Yuen KY; Zhang BZ; Chu H; Huang JD
    Cell Host Microbe; 2023 Aug; 31(8):1301-1316.e8. PubMed ID: 37527659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic heterogeneity in human genetic diseases: ultrasensitivity-mediated threshold effects as a unifying molecular mechanism.
    Sun YH; Wu YL; Liao BY
    J Biomed Sci; 2023 Jul; 30(1):58. PubMed ID: 37525275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly neutralizing humanized SARS-CoV-2 antibody binds to a conserved epitope on Spike and provides antiviral protection through inhalation-based delivery in non-human primates.
    Hermet P; Delache B; Herate C; Wolf E; Kivi G; Juronen E; Mumm K; Žusinaite E; Kainov D; Sankovski E; Virumäe K; Planken A; Merits A; Besaw JE; Yee AW; Morizumi T; Kim K; Kuo A; Berriche A; Dereuddre-Bosquet N; Sconosciuti Q; Naninck T; Relouzat F; Cavarelli M; Ustav M; Wilson D; Ernst OP; Männik A; LeGrand R; Ustav M
    PLoS Pathog; 2023 Aug; 19(8):e1011532. PubMed ID: 37531329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy.
    Mamun MAA; Zhang Y; Zhao JY; Shen DD; Guo T; Zheng YC; Zhao LJ; Liu HM
    J Biomed Sci; 2023 Jul; 30(1):60. PubMed ID: 37525190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mitochondrial alterations in human cancer progression and cancer immunity.
    Wang SF; Tseng LM; Lee HC
    J Biomed Sci; 2023 Jul; 30(1):61. PubMed ID: 37525297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serosurveillance of SARS-CoV-2 in companion animals in Sarawak, Malaysia.
    Tan CS; Bandak DB; Habeebur-Rahman SP; Tan LT; Lim LLA
    Virol J; 2023 Aug; 20(1):176. PubMed ID: 37550752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern.
    Diem G; Dichtl S; Zaderer V; Lass-Flörl C; Reindl M; Lupoli G; Dächert C; Muenchhoff M; Graf A; Blum H; Keppler OT; Wilflingseder D; Posch W
    Microbiol Spectr; 2023 Aug; 11(5):e0179323. PubMed ID: 37551989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore.
    Pung R; Kong XP; Cui L; Chae SR; Chen MI; Lee VJ; Ho ZJM
    Lancet Reg Health West Pac; 2023 Aug; 37():100849. PubMed ID: 37554470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections.
    Chemaitelly H; Ayoub HH; AlMukdad S; Faust JS; Tang P; Coyle P; Yassine HM; Al Thani AA; Al-Khatib HA; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
    J Travel Med; 2023 Sep; 30(5):. PubMed ID: 37555656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology.
    de Gier B; Huiberts AJ; Hoeve CE; den Hartog G; van Werkhoven H; van Binnendijk R; Hahné SJM; de Melker HE; van den Hof S; Knol MJ
    Nat Commun; 2023 Aug; 14(1):4793. PubMed ID: 37558656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome based analysis of circulating SARS-CoV-2 variants: approach to a universal vaccine candidate.
    Oladipo EK; Ojo TO; Olufemi SE; Irewolede BA; Adediran DA; Abiala AG; Hezekiah OS; Idowu AF; Oladeji YG; Ikuomola MO; Olayinka AT; Akanbi GO; Idowu UA; Olubodun OA; Odunlami FD; Ogunniran JA; Akinro OP; Adegoke HM; Folakanmi EO; Usman TA; Oladokun EF; Oluwasanya GJ; Awobiyi HO; Oluwasegun JA; Akintibubo SA; Jimah EM
    Genes Genomics; 2023 Dec; 45(12):1489-1508. PubMed ID: 37548884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2.
    Clairon Q; Prague M; Planas D; Bruel T; Hocqueloux L; Prazuck T; Schwartz O; Thiébaut R; Guedj J
    PLoS Comput Biol; 2023 Aug; 19(8):e1011282. PubMed ID: 37549192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 antibody response in SARS survivors with and without the COVID-19 vaccine.
    Xia CS; Zhan M; Liu Y; Yue ZH; Song Y; Zhang F; Wang H
    Int J Antimicrob Agents; 2023 Oct; 62(4):106947. PubMed ID: 37544384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized allotopic expression of mitochondrial ND6 transgene restored complex I and apoptosis deficiencies caused by LHON-linked ND6 14484T > C mutation.
    Wang J; Ji Y; Ai C; Chen JR; Gan D; Zhang J; Mo JQ; Guan MX
    J Biomed Sci; 2023 Aug; 30(1):63. PubMed ID: 37537557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
    Almalki SSR; Izhari MA; Alyahyawi HE; Alatawi SK; Klufah F; Ahmed WAM; Alharbi R
    J Multidiscip Healthc; 2023; 16():2117-2136. PubMed ID: 37529147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting human population variation in single-cell responses to SARS-CoV-2.
    Aquino Y; Bisiaux A; Li Z; O'Neill M; Mendoza-Revilla J; Merkling SH; Kerner G; Hasan M; Libri V; Bondet V; Smith N; de Cevins C; Ménager M; Luca F; Pique-Regi R; Barba-Spaeth G; Pietropaoli S; Schwartz O; Leroux-Roels G; Lee CK; Leung K; Wu JT; Peiris M; Bruzzone R; Abel L; Casanova JL; Valkenburg SA; Duffy D; Patin E; Rotival M; Quintana-Murci L
    Nature; 2023 Sep; 621(7977):120-128. PubMed ID: 37558883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis.
    Shafiee A; Amini MJ; Arabzadeh Bahri R; Jafarabady K; Salehi SA; Hajishah H; Mozhgani SH
    Eur J Med Res; 2023 Aug; 28(1):278. PubMed ID: 37559096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2.
    Fang L; Xu J; Zhao Y; Fan J; Shen J; Liu W; Cao G
    Front Microbiol; 2023; 14():1228128. PubMed ID: 37560529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.